β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus

The evidence for using combination therapy for the treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections is growing. In this study, we investigated the synergistic effect of daptomycin (DAP) combined with piperacillin-tazobactam and ampicillin-sulbactam against MRSA in t...

詳細記述

保存先:
書誌詳細
出版年:Antimicrob Agents Chemother
主要な著者: Henson, Karl Evans R., Yim, Juwon, Smith, Jordan R., Sakoulas, George, Rybak, Michael J.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2016
主題:
Experimental Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192128/
https://ncbi.nlm.nih.gov/pubmed/27821441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01564-16
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料